NeuroPace Inc director R Scott Huennekens makes first open-market buy in 12 months: $103,661
An open-market purchase on Nov 18, reported to the SEC on Nov 18. By the Insider Stock Trader: Alerts app. Information only, not investment advice.
R Scott Huennekens, a director of NeuroPace Inc (NPCE), bought 12,500 shares on Nov 18 at an average price of $8.29, a total of $103,661, according to a Form 4 filed with the SEC on Nov 18.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. Other NeuroPace Inc insiders have also bought: Three insiders made open-market purchases within 14 days, a pattern known as a cluster buy.
After the trade, the filing lists 12,500 shares held. It is the insider's first open-market purchase of NPCE in at least 12 months.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | NeuroPace Inc (NPCE) |
|---|---|
| Insider | R Scott Huennekens |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 12,500 |
| Average price | $8.29 |
| Value | $103,661 |
| Trade date | Nov 18, 2026 |
| Filed with the SEC | Nov 18, 2026, 5:09 PM ET |
| Shares held after | 12,500 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
Open the full breakdown of this NPCE trade
Read the daily insider trading roundup · Browse the latest insider buying
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.